Mind Medicine (MindMed) Inc. Stock Deutsche Boerse AG
Equities
MMQ
CA60255C8850
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.865 EUR | +0.13% | -3.32% | +132.42% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 601M 562M |
---|---|---|---|---|---|
Net income 2024 * | -94M -87.91M | Net income 2025 * | -106M -99.14M | EV / Sales 2024 * | - |
Net cash position 2024 * | 184M 172M | Net cash position 2025 * | 99.5M 93.06M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.37
x | P/E ratio 2025 * |
-5.81
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.59% |
Latest transcript on Mind Medicine (MindMed) Inc.
1 day | +0.13% | ||
1 week | -3.32% | ||
Current month | -8.12% | ||
1 month | -12.61% | ||
3 months | +136.75% | ||
6 months | +230.74% | ||
Current year | +132.42% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 21-01-13 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 22-05-22 |
Miri Wernli
PSD | President | 71 | 20-02-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 21-09-28 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 22-08-10 |
David Gryska
BRD | Director/Board Member | 68 | 23-06-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 7.865 | +0.13% | 0 |
24-04-25 | 7.855 | -3.02% | 253 |
24-04-24 | 8.1 | +0.37% | 337 |
24-04-23 | 8.07 | -0.55% | 0 |
24-04-22 | 8.115 | -0.25% | 150 |
Delayed Quote Deutsche Boerse AG, April 26, 2024 at 02:13 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MNMD Stock
- MMQ Stock